Market Place
Sourcing Support
Sientra Announces Completion & Winning Bidders of its Section 363 Sales Auction
02 Apr 2024 //
GLOBENEWSWIRE
Sientra to Pursue Sale of its Business Through Voluntary Chapter 11 Process
13 Feb 2024 //
GLOBENEWSWIRE
Sientra Reports Third Quarter Financial and Operational Results
09 Nov 2023 //
GLOBENEWSWIRE
Sientra to Present at the Stifel 2023 Healthcare Conference
08 Nov 2023 //
GLOBENEWSWIRE
Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results
30 Oct 2023 //
GLOBENEWSWIRE
Sientra Reports Record Second Quarter Financial and Operational Results
10 Aug 2023 //
GLOBENEWSWIRE
Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023
27 Jul 2023 //
GLOBENEWSWIRE
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
30 Jun 2023 //
GLOBENEWSWIRE
Sientra Announces Appointment of Alexander W. Casdin to Board of Directors
20 Jun 2023 //
GLOBENEWSWIRE
Sientra Announces FDA-Clearance of Novel Portfinder Technology
17 May 2023 //
GLOBENEWSWIRE
Sientra Reports Record First Quarter 2023 Operational Results
11 May 2023 //
GLOBENEWSWIRE
Sientra to Report First Quarter 2023 Financial Results on May 11, 2023
01 May 2023 //
GLOBENEWSWIRE
Sientra Reports Record 4Q and Full Year Revenues
30 Mar 2023 //
GLOBENEWSWIRE
Sientra to Report Fourth Quarter and Full Year 2022 Financial Results
20 Mar 2023 //
GLOBENEWSWIRE
Sientra Announces Preliminary Results from Clinical Study & The First Shipment
01 Mar 2023 //
GLOBENEWSWIRE
Sientra Announces 1-for-10 Reverse Stock Split
20 Jan 2023 //
GLOBENEWSWIRE
Sientra Expands Footprint With Regulatory Approval to Market Breast Implants
13 Dec 2022 //
GLOBENEWSWIRE
Sientra to Report Third Quarter 2022 Financial Results on November 10, 2022
31 Oct 2022 //
GLOBENEWSWIRE
Sientra Announces Pricing of $13.2 Million Public Offering
21 Oct 2022 //
GLOBENEWSWIRE
Sientra Announces Proposed Public Offering
18 Oct 2022 //
GLOBENEWSWIRE
Sientra Announces Preliminary Unaudited Third Quarter Financial Results
12 Oct 2022 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.